Literature DB >> 25303875

Olmesartan-related sprue-like enteropathy.

Naresh Bhat1, N K Anupama, Amit Yelsangikar, Kayal Vizhi.   

Abstract

Chronic diarrhea is a common clinical problem in gastroenterology practice and often difficult to diagnose the cause. Presence of villous atrophy in these subjects is not specific as differential diagnosis can be broad. Drug-induced diarrhea is often overlooked during the evaluation. We report a short series of such challenging small bowel diarrhea secondary to olmesartan-related sprue-like enteropathy.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25303875     DOI： 10.1007/s12664-014-0506-7

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


  8 in total

1.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

Review 2.  Systematic review: Sprue-like enteropathy associated with olmesartan.

Authors:  G Ianiro; S Bibbò; M Montalto; R Ricci; A Gasbarrini; G Cammarota
Journal:  Aliment Pharmacol Ther       Date:  2014-05-07       Impact factor: 8.171

3.  Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation.

Authors:  H Weclawiak; A Ould-Mohamed; B Bournet; C Guilbeau-Frugier; F Fortenfant; F Muscari; F Sallusto; C Dambrin; L Esposito; J Guitard; M Abbal; L Rostaing; N Kamar
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

4.  Villous atrophy induced by mycophenolate mofetil in renal-transplant patients.

Authors:  Nassim Kamar; Patrick Faure; Emmanuel Dupuis; Olivier Cointault; Karine Joseph-Hein; Dominique Durand; Jacques Moreau; Lionel Rostaing
Journal:  Transpl Int       Date:  2004-08-21       Impact factor: 3.782

5.  Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma.

Authors:  Marisa DeGaetani; Christina A Tennyson; Benjamin Lebwohl; Suzanne K Lewis; Hussein Abu Daya; Carolina Arguelles-Grande; Govind Bhagat; Peter H R Green
Journal:  Am J Gastroenterol       Date:  2013-05       Impact factor: 10.864

6.  Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.

Authors:  Jennifer A Nielsen; Anita Steephen; Matthew Lewin
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

7.  Severe villus atrophy and chronic malabsorption induced by azathioprine.

Authors:  Thomas R Ziegler; Concepción Fernández-Estívariz; Li H Gu; Michael W Fried; Lorraine M Leader
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

8.  Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers.

Authors:  Jonas F Ludvigsson; Lena Brandt; Scott M Montgomery; Fredrik Granath; Anders Ekbom
Journal:  BMC Gastroenterol       Date:  2009-03-11       Impact factor: 3.067
  8 in total
  4 in total

1.  Angiotensin Receptor Blockers Associated Enteropathy-Brief Report.

Authors:  Neha Gosai; Falgun Gosai
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-05-02

Review 2.  Mechanisms and management of refractory coeliac disease.

Authors:  Tom van Gils; Petula Nijeboer; Roy L van Wanrooij; Gerd Bouma; Chris J J Mulder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-08       Impact factor: 46.802

3.  The first cases of collagenous sprue successfully treated with thioguanine.

Authors:  Tom van Gils; Tine van de Donk; Gerd Bouma; Foke van Delft; E Andra Neefjes-Borst; Chris J J Mulder
Journal:  BMJ Open Gastroenterol       Date:  2016-06-27

4.  Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy.

Authors:  Marta Eusébio; Paulo Caldeira; Artur Gião Antunes; André Ramos; Francisco Velasco; Jesús Cadillá; Horácio Guerreiro
Journal:  GE Port J Gastroenterol       Date:  2015-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.